1. Home
  2. TG vs IKT Comparison

TG vs IKT Comparison

Compare TG & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$8.99

Market Cap

273.5M

Sector

Industrials

ML Signal

HOLD

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.68

Market Cap

240.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
IKT
Founded
1988
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.5M
240.1M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TG
IKT
Price
$8.99
$1.68
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$5.00
AVG Volume (30 Days)
128.1K
1.3M
Earning Date
05-07-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
57.76
EPS
0.96
N/A
Revenue
$800,821,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.31
N/A
Revenue Growth
8.29
N/A
52 Week Low
$6.25
$1.33
52 Week High
$9.66
$2.37

Technical Indicators

Market Signals
Indicator
TG
IKT
Relative Strength Index (RSI) 60.86 43.91
Support Level $8.49 $1.61
Resistance Level $9.26 $1.74
Average True Range (ATR) 0.26 0.11
MACD 0.09 0.01
Stochastic Oscillator 77.69 12.00

Price Performance

Historical Comparison
TG
IKT

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: